Australia's Starpharma hits near 2-1/2-month high on nasal spray launch in Vietnam

Starpharma Holdings

13/12/2021 04:33

** Shares of Starpharma Holdings Ltd  SPL.AX  rise as much
as 4.4% to A$1.32, their highest since Sept 30 
    ** Biopharma co says it successfully launched its trademark
antiviral nasal spray VIRALEZE in Vietnam  urn:newsml:reuters.com:*:nASN001ZN7
    ** Co has received orders in excess of A$2 mln($1.43 mln)
since late October
    ** The nasal spray is shown to be effective against COVID-19
    ** Volumes are about 1.4 times compared with the 30-day
average 563,824
    ** As of Friday's close, stock has dropped 19.2% this year

($1 = 1.3947 Australian dollars)

 (Reporting by Navya Mittal)
 ((Navya.Mittal@thomsonreuters.com;))